Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11351
Title: Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: A randomized, double-blinded, clinical trial.
Authors: Chae, John;Taylor, David McD;Frauman, Albert G
Affiliation: Department of Medicine, University of Melbourne Department of Medicine, Austin Hospital, Melbourne, Victoria, Australia. david.taylor@austin.org.au
Issue Date: 20-Jun-2011
Citation: Emergency Medicine Australasia : Ema 2011; 23(5): 554-61
Abstract: We aimed to compare the relative efficacy of tropisetron and metoclopramide in treating nausea/vomiting in undifferentiated ED patients.We undertook a randomized, double-blinded, clinical trial. Adult patients requiring treatment for nausea/vomiting were randomly assigned to either tropisetron (5 mg) or metoclopramide (10 mg), by i.v. bolus. The primary end-point was incidence of vomiting. Secondary end-points were decrease in nausea score from baseline (0-100 VAS), the requirement of 'rescue' anti-emetics, ongoing nausea over 48 h and side-effects.Fifty patients were enrolled in each group. The demographic variables, presenting complaints and nausea scores at baseline did not differ (P > 0.05). By 180 min, two (4.0%) and nine (18.0%) patients had vomited in the tropisetron and metoclopramide groups respectively (difference 14.0%, 95% CI 0.1-28.0, P= 0.05). Also, there were two and 20 episodes of vomiting respectively. Vomiting rates were 0.02 and 0.16 episodes/person-hour (difference 0.14 episodes/person-hour, 95% CI 0.07-0.21, P < 0.001) respectively. By 60 min and thereafter, the decrease in nausea score from baseline was greater (although not significantly so) in the tropisetron group. At 180 min, the decreases were 47.9 mm and 37.0 mm respectively (difference 10.9 mm, 95% CI -0.7-22.6). Five (10.0%) and 13 (26.0%) patients required a rescue anti-emetic respectively (difference 16.0%, 95% CI -0.7-32.7, P= 0.07). Of patients followed up, 13/47 (27.7%) and 20/49 (40.8%) had ongoing nausea respectively (difference 13.2%, 95% CI -7.7-34.0, P= 0.25). The tropisetron group had less akathisia.Tropisetron was associated with a significantly lower vomiting rate and shows promise as an alternative anti-emetic in the ED.
Internal ID Number: 21995469
URI: http://ahro.austin.org.au/austinjspui/handle/1/11351
DOI: 10.1111/j.1742-6723.2011.01444.x
URL: http://www.ncbi.nlm.nih.gov/pubmed/21995469
Type: Journal Article
Subjects: Adult
Aged
Antiemetics.therapeutic use
Double-Blind Method
Emergency Medical Services.methods
Emergency Service, Hospital
Female
Humans
Incidence
Indoles.therapeutic use
Male
Metoclopramide.therapeutic use
Middle Aged
Nausea.drug therapy
Vomiting.drug therapy.epidemiology
Young Adult
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.